Loading...
•
Mar 31, 2022
SI-BONE Q1 2022 Earnings Report
Reported financial results for the quarter ended March 31, 2022.
Key Takeaways
SI-BONE, Inc. reported a 10% increase in worldwide revenue, reaching $22.4 million for the first quarter of 2022. U.S. revenue increased by 9% to $20.4 million, and the gross margin was 87%. The company's operating loss was $16.9 million, and the net loss was $17.4 million, or $0.52 per diluted share.
Worldwide revenue of $22.4 million for the first quarter 2022, representing a 10% increase over the corresponding period in 2021
U.S. revenue of $20.4 million for the first quarter 2022, representing a 9% increase over the corresponding period in 2021
Gross margin of 87% for the first quarter 2022
Awarded Breakthrough Device Designation by the FDA for iFuse Bedrock GraniteTM targeting adult spinal deformity
SI-BONE
SI-BONE
Forward Guidance
The Company continues to expect total 2022 revenue of approximately $106 million to $108 million, representing growth of 18% to 20% compared to full year 2021.